Investors

Shield Therapeutics is well positioned to become a fast growing, independent, international specialty pharmaceutical company.

Advisor Contacts

Nominated Advisor and Joint Broker

Liberum, Ropemaker Place
25 Ropemaker Street, London
EC2Y 9LY

Tel: +44 (0)20 3100 2000

Joint Broker

Peel Hunt LLP
120 London Wall
London
EC2Y 5ET

Tel: +44 (0)20 7418 8900

Auditors

KPMG LLP, Quayside House, 110 Quayside
Newcastle Upon Tyne
NE1 3DX

Tel: +44 (0)19 1401 3700

Legal Advisors

Stephenson Harwood LLP
1 Finsbury Circus, London
EC2M 7SH

Tel: +44 (0)20 7329 4422

Tax Advisors

Ernst & Young LLP
Citygate
St James’ Boulevard Newcastle upon Tyne
NE1 4JD

Tel: +44 (0)19 1247 2500

Registrar

Capita Registrars Ltd
The Registry, 34 Beckenham Road
Beckenham, Kent
BR3 4TU

Tel: 0871 664 0300 / +44 (0)371 664 0300

Financial PR

Consilium Strategic Communications
41 Lothbury, London
EC2R 7HG

Tel: +44 (0)20 3709 5700

Other Research Contacts

Howard Miller, Canaccord
Nick Keher, RBC Capital

Shield Therapeutics plc

Shield Therapeutics plc
Northern Design Centre
Gateshead Quays, Gateshead
NE8 3DF

Tel: +44 (0)191 511 8500

Email: investorrelations@shieldtx.com